Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Res. 2010 Jan 1;70(1):192-201. doi: 10.1158/0008-5472.CAN-09-2641. Epub 2009 Dec 8.

ZBRK1 acts as a metastatic suppressor by directly regulating MMP9 in cervical cancer.

Author information

  • 1Institute of Basic Medical Sciences, National Cheng Kung University, Department of Pathology, Tainan, Taiwan.

Abstract

The BRCA1-interacted transcriptional repressor ZBRK1 has been associated with antiangiogenesis, but direct evidence of a tumor suppressor role has been lacking. In this study, we provide evidence of such a role in cervical carcinoma. ZBRK1 levels in cervical tumor cells were significantly lower than in normal cervical epithelial cells. In HeLa cervical cancer cells, enforced expression inhibited malignant growth, invasion, and metastasis in a variety of in vitro and in vivo assays. Expression of the metalloproteinase MMP9, which is known to be an important driver of invasion and metastasis, was found to be inversely correlated with ZBRK1 in tumor tissues and a target for repression in tumor cells. Our findings suggest that ZBRK1 acts to inhibit metastasis of cervical carcinoma, perhaps by modulating MMP9 expression.

PMID:
19996286
PMCID:
PMC3237114
DOI:
10.1158/0008-5472.CAN-09-2641
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center